Matthew A.T. Croco

Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)

Ronald N. Jones, Matthew A.T. Croco, Kari C. Kugler et al. · Diagnostic Microbiology and Infectious Disease · 2000 · 62 citations

Antibiotics, Suspected Pneumonia, Respiratory Diseases +12

In vitro evaluation of a novel orally administered cephalosporin (cefditoren) tested against 1249 recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae

Ronald N. Jones, Douglas J. Biedenbach, Matthew A.T. Croco et al. · Diagnostic Microbiology and Infectious Disease · 1998 · 46 citations

Streptococcus Pneumoniae, Antimicrobial Susceptibility, Klebsiella Pneumoniae +8

BAY 12-8039, a novel fluoroquinolone

Douglas J. Biedenbach, Mary S. Barrett, Matthew A.T. Croco et al. · Diagnostic Microbiology and Infectious Disease · 1998 · 37 citations

Bay 12-8039, Medicinal Chemistry, Medicine +7

Antimicrobial activity evaluations of gatifloxacin, a new fluoroquinolone: contemporary pathogen results from a global antimicrobial resistance surveillance program (SENTRY, 1997)

Ronald N. Jones, Matthew A.T. Croco, Michael A. Pfaller et al. · Clinical Microbiology and Infection · 1999 · 22 citations · Full text

Antimicrobial Susceptibility, Health Sciences, Antibiotics +14

Comparative In Vitro Activity of Gatifloxacin Against Stenotrophomonas maltophilia and Burkholderia Species Isolates Including Evaluation of Disk Diffusion and E Test Methods

Douglas J. Biedenbach, Matthew A.T. Croco, Timothy J. Barrett et al. · European Journal of Clinical Microbiology & Infectious Diseases · 1999 · 21 citations

Antifungal Agent, Antimicrobial Susceptibility, Disk Diffusion +9